Robot-assisted surgery: Mazor touts landmark Parkinson’s patient treated | On Call

MassDevice On Call

MASSDEVICE ON CALL — For the 1st time Mazor Robotics’ (PINK:MZRTF) Renaissance robot-assisted surgical system system was used to to treat a Parkinson’s patient, implanting a battery-sized neurostimulator that delivers mild electrical stimulation to targeted areas of the brain.

The landmark procedure took place at a Florida hospital earlier this month. Caesarea, Israel-based Mazor said 2 more patients have since been treated with positive results.

Deep-brain stimulation has been used to treat the symptoms of Parkinson’s disease in approximately 30,000 people worldwide, according to a company statement. The device maker is planning a wider 2014 commercial launch of its surgical system for use in brain procedures.

Mazor’s Renaissance robot system has been cleared in the U.S. for brain surgery, but had never before been used in a deep-brain stimulation procedure to treat Parkinson’s disease. More than 35 patients in Germany alone have successfully undergone brain biopsy procedures using the Mazor robot.

 Big companies expect a 7% increase in employee healthcare costs, survey says
In 2014 large companies expect to pay 7% more in employee healthcare benefit costs, according to a survey conducted by the National Business Group on Health. Executives made the same 7% prediction in 2012 and 2013, but this year the poll found that some are exploring the option of health insurance exchanges. Larger companies will not be allowed to enroll in government-organized health insurance exchanges until 2017. This year’s survey also found that more than 1/3 of employers believe a consumer-directed health plan is the best cost control measure.
Read more

 Using PET scans, researchers glean insights into Huntington’s disease
Researchers at the Feinstein Institute have developed a new tool to measure the progression of Huntington’s disease,
a degenerative disease that usually appears in a person’s 40s and 50s. The researchers took PET scans of 12 people with asymptomatic Huntington’s, examining them over a 7 year period. They then tallied the number of brain abnormalities seen in the images and measured the rate of the disease’s progression. Their findings may help doctors discern the effects of new drugs before symptoms appear.
Read more

 Bill Clinton going on the Obamacare campaign trail
Former President Bill Clinton is this month launching a campaign to ‘sell’ healthcare reform to the American public. The efforts will kick off with a speech on September 4, in which the former Commander in Chief is slated to discuss reform from his presidential library in Little Rock, Ark.
The White House is currently targeting young people, a key demographic that will help the law function properly if they enroll in the government insurance exchanges. Clinton’s speech will come 1 month before insurance exchanges open for business on October 1.
Read more

 Urine test might help ID cognitive decline in diabetes patients
A urine test shows promise in identifying which Type II diabetes patients are at a higher risk for cognitive impairment. Researchers found that patients with a certain protein present in urine samples had a steeper cognitive decline than patients whose urine lacked the protein. The study, slated to come out in the next issue of Clinical Journal of the American Society of Nephrology, evaluated 2,977 diabetes patients with normal kidney function over a period of 4-5 years.
Read more

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply